SG10201707504VA - Guanidinobenzoic acid ester compound - Google Patents
Guanidinobenzoic acid ester compoundInfo
- Publication number
- SG10201707504VA SG10201707504VA SG10201707504VA SG10201707504VA SG10201707504VA SG 10201707504V A SG10201707504V A SG 10201707504VA SG 10201707504V A SG10201707504V A SG 10201707504VA SG 10201707504V A SG10201707504V A SG 10201707504VA SG 10201707504V A SG10201707504V A SG 10201707504VA
- Authority
- SG
- Singapore
- Prior art keywords
- acid ester
- ester compound
- guanidinobenzoic acid
- guanidinobenzoic
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D333/40—Thiophene-2-carboxylic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013050011 | 2013-03-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201707504VA true SG10201707504VA (en) | 2017-10-30 |
Family
ID=51536870
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201707504VA SG10201707504VA (en) | 2013-03-13 | 2014-03-13 | Guanidinobenzoic acid ester compound |
| SG11201507411TA SG11201507411TA (en) | 2013-03-13 | 2014-03-13 | Guanidinobenzoic acid ester compound |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201507411TA SG11201507411TA (en) | 2013-03-13 | 2014-03-13 | Guanidinobenzoic acid ester compound |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US9969709B2 (en) |
| EP (1) | EP2975023B1 (en) |
| JP (1) | JP6314129B2 (en) |
| KR (1) | KR102145649B1 (en) |
| CN (1) | CN105051008B (en) |
| AU (1) | AU2014230583B2 (en) |
| BR (1) | BR112015022762B1 (en) |
| CA (1) | CA2905606C (en) |
| CY (1) | CY1120552T1 (en) |
| DK (1) | DK2975023T3 (en) |
| ES (1) | ES2684045T3 (en) |
| HK (1) | HK1216246A1 (en) |
| HR (1) | HRP20181371T1 (en) |
| HU (1) | HUE039526T2 (en) |
| IL (1) | IL241541B (en) |
| LT (1) | LT2975023T (en) |
| MX (1) | MX2015012604A (en) |
| MY (1) | MY194604A (en) |
| PH (1) | PH12015502023A1 (en) |
| PL (1) | PL2975023T3 (en) |
| PT (1) | PT2975023T (en) |
| RS (1) | RS57568B1 (en) |
| RU (1) | RU2661895C2 (en) |
| SG (2) | SG10201707504VA (en) |
| SI (1) | SI2975023T1 (en) |
| TR (1) | TR201809418T4 (en) |
| TW (1) | TWI666196B (en) |
| UA (1) | UA118668C2 (en) |
| WO (1) | WO2014142219A1 (en) |
| ZA (1) | ZA201506745B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2975023T3 (en) | 2013-03-13 | 2018-08-20 | Takeda Pharmaceuticals Co | Guanidine benzoic acid ester compound |
| US9346776B2 (en) | 2014-02-13 | 2016-05-24 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
| US9428470B2 (en) | 2014-02-13 | 2016-08-30 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| JP2018080109A (en) * | 2015-03-16 | 2018-05-24 | 武田薬品工業株式会社 | Therapeutic agent |
| US10017487B2 (en) | 2015-03-27 | 2018-07-10 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
| CN105218289B (en) * | 2015-10-15 | 2017-08-01 | 浙江大学 | A kind of method that unrighted acid original position hydrogenation decarboxylation prepares long chain alkane |
| US11465965B2 (en) | 2017-11-02 | 2022-10-11 | Ube Industries, Ltd. | Double-headed protease inhibitor |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5289640A (en) | 1976-01-21 | 1977-07-27 | Ono Pharmaceut Co Ltd | Guanidinobenzoic acid derivatives, and antiplasmin agents and remedies for pancreas diseases containing the said guanidinobensolc acid deriv atives |
| AU527371B2 (en) * | 1980-09-16 | 1983-03-03 | Torii & Co., Ltd. | Amidine |
| JPS5753454A (en) * | 1980-09-16 | 1982-03-30 | Torii Yakuhin Kk | Guanidinobenzoate and anticomplementary agent |
| US5116985A (en) | 1989-12-28 | 1992-05-26 | Snow Brand Milk Products Co., Ltd. | Isoquinoline derivatives and salts thereof |
| JP2886586B2 (en) | 1989-12-28 | 1999-04-26 | 雪印乳業株式会社 | Novel guanidinobenzoic acid derivatives and their acid addition salts |
| JPH0446148A (en) | 1990-06-08 | 1992-02-17 | Asahi Chem Ind Co Ltd | 4-guadininobenzoic phenyl ester derivative and protease inhibitor containing the same |
| JPH06192085A (en) | 1992-08-31 | 1994-07-12 | Yuji Inada | Therapeutic agent for mite allergy |
| EP0673924A4 (en) | 1992-12-10 | 1996-04-24 | Teikoku Chem Ind Co Ltd | Propionic acid derivative. |
| JPH0753500A (en) | 1993-08-16 | 1995-02-28 | Sanwa Kagaku Kenkyusho Co Ltd | Guanidinobenzoic acid derivative and protease inhibitor with the same as active ingredient |
| JPH0848664A (en) * | 1994-08-05 | 1996-02-20 | Hisamitsu Pharmaceut Co Inc | New guanidinobenzoic acid ester derivative |
| JPH09124571A (en) | 1995-11-01 | 1997-05-13 | Japan Tobacco Inc | Amide and its use |
| EP0893437A4 (en) | 1996-04-10 | 2000-12-27 | Ono Pharmaceutical Co | Tryptase inhibitor and novel guanidino derivatives |
| JPH10101556A (en) | 1996-09-27 | 1998-04-21 | Ono Pharmaceut Co Ltd | Factor d-inhibiting medicine |
| JPH10251239A (en) | 1997-03-14 | 1998-09-22 | Mochida Pharmaceut Co Ltd | New 4h-3,1-benzoxazin-4-one derivative |
| JPH10306025A (en) * | 1997-05-07 | 1998-11-17 | Touin Yokohama Univ | Pollen protease inhibitor |
| EP1815865A4 (en) | 2004-11-08 | 2010-08-25 | Ono Pharmaceutical Co | Therapeutic agent for diabetes comprising protease-inhibiting compound |
| WO2006050999A2 (en) | 2004-11-15 | 2006-05-18 | Obe Therapy Biotechnology S.A.S | Methods of reducing body fat |
| US20080274945A1 (en) | 2004-11-26 | 2008-11-06 | N.V. Nutricia | Infant Nutrition With Protease Inhibitor |
| EP1846379B1 (en) | 2005-01-31 | 2009-08-19 | Merck & Co., Inc. | Antidiabetic bicyclic compounds |
| JP2009523726A (en) | 2006-01-12 | 2009-06-25 | メルク エンド カムパニー インコーポレーテッド | Hydroxyalkyl arylamide derivatives |
| PL2225261T3 (en) | 2007-12-03 | 2016-09-30 | Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism | |
| CN102822154B (en) * | 2009-12-07 | 2016-06-01 | 味之素株式会社 | Heteroarylcarboxylicacid acid ester derivative |
| EP2725016B1 (en) | 2011-06-07 | 2016-12-21 | EA Pharma Co., Ltd. | Heterocyclic carboxylic acid ester derivative |
| ES2617514T3 (en) | 2011-09-15 | 2017-06-19 | Astellas Pharma Inc. | Guanidinobenzoic acid compound |
| ES2644962T3 (en) | 2012-01-03 | 2017-12-01 | Oramed Ltd. | Capsules containing oil-based liquid compositions of combined therapeutic agents to treat diabetes |
| US9024044B2 (en) | 2012-06-14 | 2015-05-05 | Ajinomoto Co., Inc. | Heteroarylcarboxylic acid ester derivative |
| EP2941267B1 (en) | 2013-01-03 | 2022-11-16 | Oramed Ltd. | Compositions for use in treating nafld |
| EP2964644B1 (en) | 2013-03-08 | 2018-12-26 | Amgen, Inc. | Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use |
| DK2975023T3 (en) | 2013-03-13 | 2018-08-20 | Takeda Pharmaceuticals Co | Guanidine benzoic acid ester compound |
| US9428470B2 (en) | 2014-02-13 | 2016-08-30 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| US9346776B2 (en) | 2014-02-13 | 2016-05-24 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
-
2014
- 2014-03-13 DK DK14763790.4T patent/DK2975023T3/en active
- 2014-03-13 SG SG10201707504VA patent/SG10201707504VA/en unknown
- 2014-03-13 UA UAA201509922A patent/UA118668C2/en unknown
- 2014-03-13 HU HUE14763790A patent/HUE039526T2/en unknown
- 2014-03-13 CN CN201480014813.4A patent/CN105051008B/en active Active
- 2014-03-13 TR TR2018/09418T patent/TR201809418T4/en unknown
- 2014-03-13 RU RU2015143562A patent/RU2661895C2/en active
- 2014-03-13 PL PL14763790T patent/PL2975023T3/en unknown
- 2014-03-13 BR BR112015022762-7A patent/BR112015022762B1/en active IP Right Grant
- 2014-03-13 RS RS20180861A patent/RS57568B1/en unknown
- 2014-03-13 PT PT147637904T patent/PT2975023T/en unknown
- 2014-03-13 SG SG11201507411TA patent/SG11201507411TA/en unknown
- 2014-03-13 JP JP2015505541A patent/JP6314129B2/en active Active
- 2014-03-13 US US14/775,274 patent/US9969709B2/en active Active
- 2014-03-13 LT LTEP14763790.4T patent/LT2975023T/en unknown
- 2014-03-13 SI SI201430865T patent/SI2975023T1/en unknown
- 2014-03-13 TW TW103109057A patent/TWI666196B/en active
- 2014-03-13 MY MYPI2015703099A patent/MY194604A/en unknown
- 2014-03-13 EP EP14763790.4A patent/EP2975023B1/en active Active
- 2014-03-13 AU AU2014230583A patent/AU2014230583B2/en active Active
- 2014-03-13 ES ES14763790.4T patent/ES2684045T3/en active Active
- 2014-03-13 KR KR1020157027906A patent/KR102145649B1/en active IP Right Grant
- 2014-03-13 WO PCT/JP2014/056601 patent/WO2014142219A1/en active Application Filing
- 2014-03-13 MX MX2015012604A patent/MX2015012604A/en active IP Right Grant
- 2014-03-13 CA CA2905606A patent/CA2905606C/en active Active
-
2015
- 2015-09-09 PH PH12015502023A patent/PH12015502023A1/en unknown
- 2015-09-10 IL IL241541A patent/IL241541B/en active IP Right Grant
- 2015-09-11 ZA ZA2015/06745A patent/ZA201506745B/en unknown
-
2016
- 2016-04-13 HK HK16104215.3A patent/HK1216246A1/en unknown
-
2018
- 2018-08-09 CY CY20181100832T patent/CY1120552T1/en unknown
- 2018-08-27 HR HRP20181371TT patent/HRP20181371T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2960234A4 (en) | Trk-INHIBITING COMPOUND | |
| DK2850067T3 (en) | carboxylic acid | |
| EP2970081A4 (en) | Salts of treprostinil | |
| HRP20181371T1 (en) | Guanidinobenzoic acid ester compound | |
| GB201302368D0 (en) | Compound | |
| RS58594B1 (en) | Dimethylbenzoic acid compounds | |
| PT2860211T (en) | Phosphoric acid ester compositions with reduced hygroscopy | |
| HK1222385A1 (en) | Dicarboxylic acid compound | |
| EP2982674A4 (en) | Pyridinylpyrazoloquinoline compound | |
| EP2947066A4 (en) | Phenoxyalkylamine compound | |
| SG10201401381SA (en) | Acid injection | |
| GB201307331D0 (en) | Compound | |
| EP2984062A4 (en) | Hydrolysis of an ester compound | |
| GB201408643D0 (en) | Compound | |
| TH1501005372A (en) | Guanidinobenzoic acid ester compound | |
| TH1401007860A (en) | Dimethyl-benzoic acid compound | |
| TH1401006870A (en) | Carboxylic acid compounds | |
| GB201322438D0 (en) | Compound | |
| GB201315772D0 (en) | Compound | |
| GB201305634D0 (en) | Compound | |
| GB201304250D0 (en) | Compound | |
| GB201301585D0 (en) | Compound |